Matinas Biopharma Holdings, Inc. (MTNB): Price and Financial Metrics
MTNB Price/Volume Stats
| Current price | $0.88 | 52-week high | $9.60 |
| Prev. close | $0.83 | 52-week low | $0.47 |
| Day low | $0.80 | Volume | 323,000 |
| Day high | $0.96 | Avg. volume | 334,699 |
| 50-day MA | $0.66 | Dividend yield | N/A |
| 200-day MA | $1.49 | Market Cap | 4.46M |
MTNB Stock Price Chart Interactive Chart >
Matinas Biopharma Holdings, Inc. (MTNB) Company Bio
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing therapeutics for the treatment of fungal and bacterial infections.
MTNB Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MTNB Price Returns
| 1-mo | 24.29% |
| 3-mo | 59.42% |
| 6-mo | 55.75% |
| 1-year | -88.86% |
| 3-year | -97.87% |
| 5-year | -97.97% |
| YTD | 72.55% |
| 2024 | -95.28% |
| 2023 | -56.76% |
| 2022 | -50.50% |
| 2021 | -25.74% |
| 2020 | -40.09% |